Product Information

PHENYLEPHRINE 2.5% EYE DROP is a generic product labeled by Leading Pharma, LLC, priced at $9.0676 per ML under NDC 69315032308. Its NADAC has been published 107 times since Nov 6, 2024.

FDA first approved this application on May 23, 2024. Its Orange Book therapeutic-equivalence code is AT.

PHENYLEPHRINE 2.5% EYE DROP

PHENYLEPHRINE HYDROCHLORIDE
$9.0676per ML

Strength

25 mg/mL

NDC

69315032308

Classification

Generic

Dosage Form

SOLUTION

Route

OPHTHALMIC

Effective Date

11/18/2026

Active Ingredients

PHENYLEPHRINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA215183

FDA Approved

5/23/2024

TE Code

AT

On Market Since

9/5/2024

Pharmacological Classes

Adrenergic alpha1-Agonists
alpha-1 Adrenergic Agonist

Price Statistics

The NADAC for PHENYLEPHRINE 2.5% EYE DROP has been published 107 times since Nov 6, 2024, and over the history we have for it it has declined 34.1%. The table below summarizes its recorded NADAC range and movement.

Current price$9.0676 per ML
All-time high$13.7575 (Nov 13, 2024)
All-time low$8.5534 (Feb 18, 2026)
52-week high$9.9766
52-week low$8.5534
Median price$11.3334
Average price$11.0300
Largest weekly change-12.0% (Nov 19, 2025)
Weeks tracked107
Tracking sinceNov 6, 2024

Price History

1W

-0.2%

1M

-0.2%

3M

-1.4%

6M

-0.2%

1Y

-9.1%

3Y

N/A

5Y

N/A

All

-34.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the PHENYLEPHRINE HYDROCHLORIDE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PHENYLEPHRINE 2.5% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for PHENYLEPHRINE 2.5% EYE DROP, manufactured by Leading Pharma, LLC, is $9.0676 per ML (NDC 69315032308), effective Nov 18, 2026.

How has the price of PHENYLEPHRINE 2.5% EYE DROP changed over time?

Over the history we have for it, the NADAC for PHENYLEPHRINE 2.5% EYE DROP has declined 34.1%. It has been tracked across 107 weekly CMS publications since Nov 6, 2024.

What are the highest and lowest recorded NADAC prices for PHENYLEPHRINE 2.5% EYE DROP?

Since Nov 6, 2024, the NADAC for PHENYLEPHRINE 2.5% EYE DROP has ranged from a low of $8.5534 (Feb 18, 2026) to a high of $13.7575 (Nov 13, 2024), with a median of $11.3334 per ML.

Are there cheaper alternatives to PHENYLEPHRINE 2.5% EYE DROP?

No other NADAC-published product currently shares the active ingredient and strength of PHENYLEPHRINE 2.5% EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PHENYLEPHRINE 2.5% EYE DROP?

PHENYLEPHRINE 2.5% EYE DROP (NDC 69315032308) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.